ClinicalTrials.Veeva

Menu

Cardiac Rehabilitation for Cardiovascular Risk Reduction in People With Severe and Persistent Mental Illness

L

Lady Davis Institute

Status

Enrolling

Conditions

Cardiovascular Prevention
Mental Illness Persistent

Treatments

Behavioral: Cardiac Rehabilitation Program

Study type

Interventional

Funder types

Other

Identifiers

NCT05659498
20233395

Details and patient eligibility

About

The goal of this prospective, randomized trial is to explore the link between cardiovascular disease and mortality in individuals with severe and persistent mental illness (SPMI). The main question it aims to answer is: Is a primary prevention cardiac rehabilitation intervention feasible and effective at reducing cardiovascular risk in people with a primary psychotic disorder or bipolar disorder?"

Participants will undergo a multi-component primary prevention intervention program. Researchers will compare with a control group to see if cardiovascular risk reduction is attained.

Full description

This prospective, randomized study aims to recruit 46 adults with schizophrenia, schizoaffective disorder, or bipolar disorder, who are classified as intermediate or high 10-year risk for a cardiovascular event, into a multi-component cardiac rehabilitation intervention program. The aim is to explore the feasibility and efficacy of this multi-component primary prevention intervention program in reducing cardiovascular risk in individuals with SPMI.

Evidence supports a high burden of cardiovascular disease and mortality in individuals with SPMI. In link, multiple studies outline disparities in access to quality cardiovascular care in people with SPMI. Given the high CV risk factor burden in people with SPMI and the disparity in access and quality of care, there is a need to screen for CV risk factors and initiate and monitor guideline-directed therapies in people with SPMI.

Intervention outcomes will be measured using the Framingham 10-year cardiovascular risk score, the Framingham 30-year cardiovascular risk score, the PRIMOSE BMI and Lipid risk scores, the EQ-5D-5L scale and the CGI score. Continuous variables will be displayed as means, with associated standard deviations. Categorical variables will be represented as frequencies and percentages. Subsequent comparative analysis will take place, where the overall cohort will be characterized into high risk (top quartile) and low risk (bottom quartile) cohorts. This will be accomplished using the chi-squared test or the Fisher exact test, along with the student's t test and the Mann-Whitney U test when appropriate. SPSS 24.0 will be the statistical software used.

Enrollment

46 estimated patients

Sex

All

Ages

30 to 59 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age ≥ 30 to 59 years old
  • Psychiatric diagnosis of schizophrenia, schizoaffective disorder, or bipolar I disorder
  • 2 or more cardiac risk behaviors or conditions: smoking, obese, hypertension, diabetes, metabolic syndrome, dyslipidemia, obstructive sleep apnea
  • 10-year Framingham cardiovascular risk score of ≥ 10% (intermediate risk)
  • Willing to participate in cardiac rehabilitation program

Exclusion criteria

  • Psychiatric instability, as judged by treating psychiatrist
  • Distance from cardiac rehabilitation centre that would preclude participation
  • Unsafe to participate in the cardiac rehabilitation intervention, as judged by the cardiology assessment
  • Pregnant
  • Known coronary artery disease, cerebrovascular disease, or peripheral vascular disease
  • Court ordered mandatory or tutor

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

46 participants in 2 patient groups

Intervention
Experimental group
Description:
The standard cardiac rehabilitation program consists of the following: a (1) consultation with a kinesiologist to assess level of fitness and to prepare an individually customized exercise plan, (2) consultation with a dietitian to guide the participant with healthy nutrition choices, (3) on site supervised and/or virtual exercise sessions with gradual elaboration of a home program, (4) weekly educational capsules and monthly workshops related to cardiac health, and, (5) if deemed necessary by the treating team, consultation with a psychologist, an occupational therapist, a physiotherapist, or a social worker.
Treatment:
Behavioral: Cardiac Rehabilitation Program
Control
No Intervention group
Description:
Participants in the control group will receive educational information on maintaining optimal cardiovascular health. Participants will be encouraged to undergo 30 minutes of moderate-intensity aerobic activity at least 5 days per week. Participants will be given educational materials on recommended diet and exercise.

Trial contacts and locations

1

Loading...

Central trial contact

Michael J Goldfarb, MD MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems